Case ReportPublished 9 October 2026Durable partial response with low-dose, intermittent nivolumab in combination with gemcitabine for high PD-L1 metastatic triple-negative breast cancer: a case reportPo Lin Ooi · Jamin Munchar Elias · Francis Yew Fu TiengFrontiers in Oncologydoi 10.3389/fonc.2026.1964934
